NCT03226795

Improving Therapeutic Adherence With a Co-constructed Program Involving Both Patients and Health Care Professionals

Improving Therapeutic Adherence of Adult Patients With Cystic Fibrosis: Impact of a Co-constructed Program by Patients and Health Caregivers.

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 450 (estimated)
• Sponsor: Hospices Civils de Lyon · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Background Cystic fibrosis is a life-threatening genetic disorder responsible for pulmonary failure and multi-systemic complications involving specific and large medical care burden. To date, no program has shown its effectiveness in improving therapeutic adherence. A new approach to develop a co-constructed program involving patients and professionals may contribute to improve therapeutic adherence. Objectives The aim of the MUCOBS-Trial project is to create a program to increase therapeutic adherence and to evaluate its efficacy in adult patients with cystic fibrosis in 3 CF centers in France.

Conditions

• Cystic Fibrosis

Interventions

Type	Name	Description
OTHER	" Information-Motivation-Behavioral skills " intervention.	* "information" -\> Reminders of medication: mobile application * "Motivation" -\> Coaching by patients: intervention or coaching by an expert patient, animation of a social network of patients * "Behavioral skills" -\> Accompaniment by professionals: therapeutic education, assessment of membership during medical visits, prioritization of treatments

Timeline

• Start date: 2021-01-18
• Primary completion: 2023-04-18
• Completion: 2025-10-18
• First posted: 2017-07-24
• Last updated: 2022-03-25

Locations

3 sites across 1 country: France